摘要
载脂蛋白E4(apoE4),最常见的阿尔茨海默氏病(AD)的遗传危险因素,与神经元和血管损伤有关。最近的研究结果表明apoE4老鼠的视网膜有突触受损和功能障碍。我们目前研究apoE4对视网膜和脉络膜的脉管系统的影响及在这些影响中血管内皮生长因子可能产生的作用。apoE3和apoE4幼鼠的视网膜与脉络膜的血管没有组织学差异。相反,apoE4老鼠较apoE3老鼠因激光所致脉络膜损伤诱发更高水平的脉络膜新生血管性疾病(CNV)。apoE4老鼠更明显地表现出这些影响与炎症反应以及米勒细胞、星形细胞标记物、谷胱甘肽合成酶和胶质纤维酸性蛋白的激活有关。然而,apoE3和apoE4幼鼠中CNV同样会诱发类似的突触标记物突触素和突触后密度蛋白95抗体水平的短暂增加。apoE4老鼠的视网膜和脉络膜的血管内皮生长因子和载脂蛋白E水平较apoE3老鼠的含量低。相比之下, apoE4老鼠较apoE3老鼠因激光损伤所致血管内皮生长因子和载脂蛋白E水平上升更显著。总的来说,这些发现表明:在基础条件下,apoE4诱发的视网膜损伤可能与这些老鼠眼睛中降低的血管内皮生长因子水平有关。apoE4老鼠高发新生血管性疾病可能取决于炎症反映增加和受损后相关的血管内皮生长因子激增。
关键词: 阿尔茨海默氏病;载脂蛋白E4;脉络膜;新生血管性疾病;视网膜;突触;目标替代鼠;血管内皮生长因子。
Current Alzheimer Research
Title:VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina
Volume: 12 Issue: 4
Author(s): Ran Antes, Shiran Salomon-Zimri, Susanne C. Beck, Marina Garcia Garrido and Tami Livnat, Idit Maharshak, Tamar Kadar, Mathias Seeliger, Dov Weinberger and Daniel M. Michaelson
Affiliation:
关键词: 阿尔茨海默氏病;载脂蛋白E4;脉络膜;新生血管性疾病;视网膜;突触;目标替代鼠;血管内皮生长因子。
摘要: Apolipoprotein E4 (apoE4), the most prevalent genetic risk factor for Alzheimer's disease (AD), is associated with neuronal and vascular impairments. Recent findings suggest that retina of apoE4 mice have synaptic and functional impairments. We presently investigated the effects of apoE4 on retinal and choroidal vasculature and the possible role of VEGF in these effects. There were no histological differences between the retinal and choroidal vasculatures of naïve apoE3 and apoE4 mice. In contrast, laserdriven choroidal injury induced higher levels of choroidal neovascularization (CNV) in apoE4 than in apoE3 mice. These effects were associated with an inflammatory response and with activation of the Muller cells and asrocytic markers gluthatione synthetase and GFAP, all of which were more pronounced in the apoE4 mice. CNV also induced a transient increase in the levels of the synaptic markers synaptophysin and PSD95 which were however similar in the apoE4 and apoE3 naive mice. Retinal and choroidal VEGF and apoE levels were lower in naïve apoE4 than in corresponding apoE3 mice. In contrast, VEGF and apoE levels rose more pronouncedly following laser injury in the apoE4 than in apoE3 mice. Taken together, these findings suggest that the apoE4-induced retinal impairments, under basal conditions, may be related to reduced VEGF levels in the eyes of these mice. The hyper-neovascularization in the apoE4 mice might be driven by increased inflammation and the associated surge in VEGF following injury.
Export Options
About this article
Cite this article as:
Ran Antes, Shiran Salomon-Zimri, Susanne C. Beck, Marina Garcia Garrido and Tami Livnat, Idit Maharshak, Tamar Kadar, Mathias Seeliger, Dov Weinberger and Daniel M. Michaelson , VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina, Current Alzheimer Research 2015; 12 (4) . https://dx.doi.org/10.2174/1567205012666150325182504
DOI https://dx.doi.org/10.2174/1567205012666150325182504 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stable Angina Pectoris: Current Medical Treatment
Current Pharmaceutical Design Nutraceuticals, Nutritional Therapy, Phytonutrients, and Phytotherapy for Improvement of Human Health: A Perspective on Plant Biotechnology Application
Recent Patents on Biotechnology Plastid Molecular Pharming II. Production of Biopharmaceuticals by Plastid Transformation
Mini-Reviews in Medicinal Chemistry Safety Analysis and Improved Cardiac Function Following Local Autologous Transplantation of CD133+ Enriched Bone Marrow Cells After Myocardial Infarction
Current Neurovascular Research Prophylaxis of Cancer
Current Cancer Therapy Reviews New Hybrid Method for Left Ventricular Ejection Fraction Assessment from Radionuclide Ventriculography Images
Current Medical Imaging Role of Gap Junction Channel in the Development of Beat-to-Beat Action Potential Repolarization Variability and Arrhythmias
Current Pharmaceutical Design Metabolomics Reveals Hyperlipidemic Biomarkers and Antihyperlipidemic Effect of Poria cocos
Current Metabolomics Bone Loss and Osteoporosis are Associated with Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
Current Alzheimer Research Periodontal Disease and Periodontal Tissue Regeneration
Current Stem Cell Research & Therapy Hematocrit-lowering Effect Following Inactivation of Renin-Angiotensin System with Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Current Topics in Medicinal Chemistry The Relationship Between Personality Types and Sexual Dysfunction
Current Women`s Health Reviews Inhibition of Early Upstream Events in Prodromal Alzheimer’s Disease by Use of Targeted Antioxidants
Current Aging Science Current Place of Beta-Blockers in the Treatment of Hypertension
Current Vascular Pharmacology How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy
Anti-Cancer Agents in Medicinal Chemistry Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1), a Relevant Target for Diabetic Vasculopathy?
Cardiovascular & Hematological Disorders-Drug Targets Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants
Current Pharmaceutical Design The Evil Axis of Obesity, Inflammation and Type-2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Myocardial Revascularization Strategies in Diabetic Patients with Multi-Vessel Disease: CABG vs DES-Based PCI
Current Pharmaceutical Design Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials
Current Clinical Pharmacology